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ABSTRACT
Quantitative tools to assess vascular macromolecular distributions have so far
been limited by post-experiment artifact, low signal-to-noise ratios, limited spatial
resolution, and the inability to provide multi-dimensional drug distribution profiles. This
suggests the need to develop new techniques that overcome these limitations. A new
technique combining fluorescence microscopy with digital post-processing has been
developed. Quantitative fluorescence microscopy studies have been limited by
autofluorescence, the process where endogenous compounds emit energy at the same
wavelength as fluorescent labels, and the proper conversion of fluorescent intensities to
physical concentrations. Specimens were imaged with two different filter sets with one
image consisting of signal from both autofluorescent molecules and fluorescent labels and
the other image containing signal only from autofluorescence. The latter image is then
used to estimate the autofluorescence in the former. Subtraction of the estimated
autofluorescence results in an autofluorescence-free image. A standard curve to convert
fluorescent intensities to macromolecular concentrations was constructed by examining
tissue specimens that were incubated until equilibrium in different concentrations. The
end result is a two-dimensional concentration profile with spatial resolution superior to
many of the previous methods to quantify macromolecular distributions. To illustrate the
utility of this technique, the transvascular transport of fluorescently labeled 20 kD
dextrans in the calf carotid artery is examined using an in vitro perfusion apparatus. A
mathematical model of transport is evaluated using measured concentration profiles
yielding estimates of important transport parameters such as the effective diffusivity, and
endovascular and perivascular permeabilities. Future experiments incorporating this new
technique will be able to elucidate details of macromolecular transport which can then be
used to improve the efficacy and efficiency of drug delivery systems.
Thesis Supervisor: Elazer R. Edelman
Title: Thomas D. and Virginia W. Cabot Associate Professor, Division of Health Sciences
and Technology
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I. Introduction
.A. Statement of the Problem
Tissue culture and animal studies have elucidated many details about the
pathobiology of different diseases and this mechanistic information has suggested a
number of biologic and synthetic therapeutic agents. Surprisingly, the tremendous
potential of these drugs has not always been realized. Two alternatives arise in describing
this paradox; either the drugs are ineffective for their intended use, or they do not reach
their intended target at sufficient doses or with necessary timing to elicit the expected
response. The issue as to which explanation predominates can be determined by in depth
tracking of drug deposition and metabolism. Traditionally known as pharmocokinetics,
this field of study has been hindered by limitations in the techniques used to assess the
distribution of therapeutic compounds. Such problems are especially prominent in the
blood vessel with post-experiment artifact, low signal-to-noise ratios, limited spatial
resolution and the inability to acquire multi-dimensional drug distribution profiles. This
suggests the need to develop new techniques to quantify concentration profiles to obtain
better experimental data.
LB. Thesis Organization
This thesis describes the development of a new technique to quantitatively assess
the distribution of macromolecules in vascular tissue. Chapter 2 introduces the clinical
and scientific motivation for developing a new method to measure macromolecular
concentration profiles. Chapter 3 discusses the development of this new technique which
integrates quantitative fluorescence microscopy with digital post processing. Chapter 4
demonstrates the utility of this new method to measure macromolecular distributions.
The new technique is combined with in vitro experiments and mathematical modeling to
investigate the transvascular transport of fluorescently labeled 20 kD dextrans in the calf
carotid artery. Chapter 5 summarizes the work in this thesis and suggests applications of
this work to further understanding of the pharmacokinetics following drug delivery.
II. Background
II.A. Motivation
Modern medicine has identified the molecular and biochemical defects of many
diseases. For example, proliferative vascular diseases have been shown to result from a
disruption of the normal checks and balances and sophisticated nature of cell-cell and cell-
tissue relationships (Ross 1993). Delineation of specific endogenous compounds that
inhibit and/or promote homeostasis have suggested avenues for the administration of
vasotherapeutic compounds to specific portions of the blood vessel wall. As in general
pharmacology, therapeutic options for vascular disease include an increasing number of
potential biologic and synthesized agents. Yet the administration of these drugs is not
straightforward, and is complicated by narrow therapeutic ranges, and short half-lifes.
When there exists minor differences between drug levels that are subtherapeutic,
efficacious, and toxic, for agents that may also be quickly degraded or cleared by the
circulatory system before they exert their biologic effect, problems arise.
The sustained release of such drugs might help regulate drug concentrations within
defined therapeutic ranges for prolonged periods of time. These ideas can be obtained by
a variety of delivery devices, including those that involve pumps or polymeric devices
(Langer and Moses 1991; Nimni 1997). Many studies have quantified drug release for
different delivery strategies. However, further research is required as the release
characteristics of these delivery systems only partially determines the efficacy of the
delivered compound. In addition to the pattern of drug release, the biologic effect of an
administered compound is determined by its transport, deposition, and clearance.
Transport refers to the propagation of the agent through tissue, deposition is the
localization of the bioactive compound, and clearance determines the duration that the
compound can exert its biologic effect. Like release, the quantitative detection of each of
these three phenomena is determined by the sensitivity and resolution of the techniques
available.
To date, quantitative tools to assess vascular distribution of macromolecules have
so far been limited by post-experiment artifact, low signal-to-noise ratios, spatial
resolution, and the inability to provide multi-dimensional drug distribution profiles.
These issues have restricted experiments on the pharmacokinetics after administration,
suggesting that new techniques be developed. Once available, sensitive techniques could
be utilized to gain insight into pharmacological delivery strategies and devices. It would
be especially helpful, for example, to know if a pharmacological failure arises from
biological inefficacy or from inadequate distribution. In addition to improving the
efficiency and successfulness of pharmacological therapy, this research will elucidate
details of blood vessel physiology and homeostasis in states of health and disease.
IL.B. Proliferative Vascular Diseases
Many areas of medical research could utilize techniques to assess drug
concentrations in tissue to further understanding of the underlying physiology and assist
the design of potential pharmacological therapies. One field where these techniques could
have substantial impact is the treatment of proliferative vascular diseases. These diseases
are the leading cause of morbidity and mortality in the world today, accounting for over 1
million deaths and almost 1.5 million interventions each year in the United States alone.
Tissue culture and animal studies have elucidated many of the details concerning
pathobiology of these diseases, but all treatments developed so far have only had
temporarily benefits. Mechanical revascularizations such as percutaneous transluminal
coronary angioplasty and endovascular stent placement have inevitably been followed by
accelerated vascular diseases in response to the mechanical injury (Schwartz, Huber et al.
1992; Rogers and Edelman 1995). Many pharmacological agents have also been
developed to treat proliferative vascular diseases either alone or in conjunction with
mechanical revascularization. However, the tremendous potential of pharmacological
therapies has been limited by the lack of understanding of the pharmacokinetics within
the vessel wall. This is partly the result of limitations in current techniques to measure
the vascular distribution of compounds such as low spatial resolution. The development
of tools to assess vascular distributions and insight gained from experiments using these
techniques is needed to realize the potential of proposed pharmacological therapies. A
review of vascular architecture and physiology will put into context many of the terms
and concepts used in this work.
II.B.1. Structure of the Artery
Arteries are best described as vascular structures that carry blood away from the
heart to distal tissues. They are comprised of three morphologically distinct concentric
tunics or layers. The innermost layer, the tunica intima, is composed of a monolayer of
endothelial cells supported by the internal elastic lamina, a layer of connective tissue
comprised mainly of elastin. In addition to being thromboresistant and transducing
signals for cells within the arterial wall, the endothelium modulates transport for many
compounds between the vessel wall and the interior of the artery known as the lumen or
endovascular space. In humans and higher animal species, there may also be some
vascular smooth muscle cells between the endothelial monolayer and the internal elastic
lamina. The middle layer, the tunica media, is composed of circumferentially aligned
smooth muscle cells and thin sheets of connective tissue such as collagen and elastin. The
contraction and relaxation of smooth muscle cells modulates the vessel diameter,
controlling the perfusion through the artery to downstream tissues. The media is
separated from the outermost layer, the tunica adventitia, by a fenestrated sheet of
elastin, the external elastic lamina. The adventitia is composed primarily of type I
collagen with loosely arranged fibroblasts and smooth muscle cells. The adventitia
gradually blends into the surrounding fascia and fat, sometimes referred to as the
perivascular space. In arteries that are approximately 0.5 mm or thicker, this layer
contains vasa vasorum, blood vessels within the blood vessel wall, that help perfuse cells
within the vessel wall.
Cells in the arterial wall can communicate with, and regulate each other, by
secreting biochemical compounds. For example, the release of growth factors such as
endothelial-derived relaxation factor (EDRF) or nitrous oxide (NO) by endothelial cells
causes smooth muscle cells in the media to relax, resulting in vasodilation and increased
blood flow to downstream tissues. Biochemical signals can also promote and inhibit the
growth of other cells, thereby controlling vascular structure and function. Injured vascular
smooth muscle cells secrete compounds such as basic fibroblast growth factor (bFGF)
which are mitogenic to both endothelial and smooth muscle cells. This process appears to
be a part of the natural reparative response of the vessel wall. Confluent endothelial cells
secrete compounds such as heparan sulfate proteoglycans (HSPG) which inhibit smooth
muscle cell growth that may provide negative feedback to healing processes. Vascular
function is dependent on cells communicating and regulating each other, and dysfunction
of these processes often leads to disease states.
In the calf carotid artery, the animal model that will be used in studies described
later in this work, the diameter of the artery is 3-4 mm and the thicknesses of the intima,
media, and adventitia are approximately 100-200 tm, 300-400 um, and 200-300 um,
respectively. Figure 1 shows a cross-section of a calf carotid artery magnified 100x under
a light microscope. The specimen in Figure 1 has been Verhoff stained to highlight elastin,
a common component of the vessel wall. This figure illustrates the inhomogeneity of
vascular tissue which complicates modeling of transport within the vessel wall.
endothelium and internal external elastic
elastic lamina (IEL) lamina (EEL)
Figure 1. Image of a cross-section of a calf carotid artery.
The specimen was magnified 100x under a light microscope,
and Verhoff stained to discriminate different layers and
structures.
II.B.2. Disease States
The most prevalent cardiovascular disease is atherosclerosis, the formation of
thickened and hardened lesions in medium and large muscular and elastic arteries. The
atherosclerotic process probably begins as a reparative response to injury and/or
dysfunction of the endothelium and/or smooth muscle cells. Leukocytes and
macrophages adhere to the vessel and migrate subendothelially. The macrophages
accumulate lipids, forming fatty streaks in the vessel wall. Some of the macrophages may
emigrate back into the bloodstream after pushing apart thromboresistant endothelial cells,
resulting in thrombosis at the injured site and the release of potent growth promoting
factors in response to this vascular injury. Various forms of the hyperproliferative
response cause the progression of the fatty streak to fibrofatty and fibrous lesions in the
intima. These lesions cause the vessel to lose its elasticity and narrow the lumen, limiting
the blood supply to downstream tissues and/or organs.
II.B.3. Treatment Options
Treatment of proliferative vascular diseases has not been straightforward.
Currently, mechanical interventions, such as endovascular stenting, balloon angioplasty,
and bypass surgery, are the default therapies. The temporary increase in vessel diameter
has inevitably been followed by renarrowing of the lumen due to the reparative response
to the mechanical injury, referred to as intimal hyperplasia or restenosis. Pharmacological
therapies are also being investigated, but despite cell culture and animal studies which
have suggested classes of bioactive compounds that should limit these diseases, none have
been successful clinically. Pharmacological therapy can be classified into two categories:
systemic and local delivery. Systemic administration such as by intravenous injection
requires the agent to circulate throughout the body. Systemic delivery is often ineffective
because the non-specificity of many compounds can injure nontarget tissues and organs,
the marked systemic toxicity of some compounds, and rapid degradation of others. Local
administration attempts to delivery drugs to a specific site, and can be classified by the
pattern of delivery. Bolus delivery can be obtained from permeable balloon catheters and
sustained delivery from devices such as polymeric release formulations which can be
implanted on or near the endovascular and perivascular surfaces. The potential to deliver
therapeutic levels of drugs without adverse systemic effects has made local delivery an
exciting area of research. This new technology has only recently begun to be studied
rigorously and may be more difficult to analyze than systemic delivery because of the
small quantities of drug being used. The use of local concentration gradients suggests that
it is very important to understand the transport and deposition of compounds following
administration.
II.C. Assessing Macromolecular Distributions
Both radioactive and nonradioactive techniques have been developed to
quantitatively assess macromolecular distributions. A review of developed techniques
will demonstrate the limitations of current methods and the necessity to develop a new
technique that overcomes some of these limitations.
II.C.1. Radioactive Techniques
Most pharmacokinetic studies have tracked the compound of interest by labeling
it with radioactive nuclides, such as tritium (3H) or radioiodine (125I). Detection and
measurement of radioactivity is usually straightforward and attachment of a radiolabel
minimally changes the physical structure of a compound and its transport properties.
Radioactivity counts can then be converted to physical concentrations of the compound
of interest. However, studies utilizing radiolabels often have limited spatial resolution
and are complicated by environmental and health hazards.
A simple, low spatial resolution method to quantify deposition is to count the
radioactivity in bulk tissue sections (Duncan, Buck et al. 1963). This method is
commonly used in studies with small tissues that are difficult to reliably section with a
microtome. Yet, it is limited by its spatial resolution and repeatability, and only
measures the average radioactivity for a bulk tissue section without providing a
quantitative description of the distribution within the tissue. In addition to assessment of
net drug within bulk tissue sections, radioactive counts of the endovascular and
perivascular solutions can be integrated with a mathematical model to analytically solve
for transport parameters. Previous work in our laboratory has demonstrated the utility of
this approach for examining the transmural transport of tritium-labeled heparin in the rat
abdominal aorta (Lovich and Edelman 1995).
Higher spatial resolution can be obtained for tissues large enough to be sectioned
with a microtome. The artery can be sliced longitudinally, unfolded, and sectioned
parallel to the intimal surface. The radioactivity of these en face serial sections can be
used to construct one-dimensional transvascular concentration profile. This technique is
commonly used to study the transport of a variety of compounds in different animal
models including the movement of radioiodinated albumin in the abdominal aorta of the rat
(Tedgui, Merval et al. 1992) and young pig (Bell, Adamson et al. 1974), and rabbit
thoracic aorta (Bratzler, Chisolm et al. 1977; Ramirez, Colton et al. 1984), radioiodinated
fibrinogen in the normal pig abdominal aorta (Bell, Gallus et al. 1974), and radioiodinated
low-density lipoprotein in the rabbit thoracic aorta (Bratzler, Chisolm et al. 1977). The
resolution of this technique is limited by the fact that slice thicknesses of 10-20 gm are
required for reliable sectioning. Axial or circumferential concentration profiles may be
obtained by orientating the artery differently in the microtome, but this technique cannot
be adapted to provide multi-dimensional distribution profiles of a single specimen.
Another method for converting the signal from radiolabels to macromolecular
concentrations is autoradiography or microautoradiography (Aitken, Wright et al. 1968;
Fry, Mahley et al. 1980; Schnitzer, Morrel et al. 1987; Tompkins, Yarmush et al. 1989).
This involves sectioning the tissue in cross-section, juxtaposing these sections to
specially prepared photographic film, and exposing the film for days to months. A linear
relationship between the silver in the developing film and its exposure to radiation allows
intensities of grains in the film to be converted to concentrations, creating a two-
dimensional concentration profile. There are many different variations of this commonly
used technique. Microautoradiography differs from autoradiography in that the section is
dipped into an emulsion silver preparation which then acts as the developing media.
Dipping the specimen into the silver preparation reduces the scatter from each radioactive
source since the source and developing media are closer together, but may cause soluble
compounds to diffuse resulting in loss of signal and artifact. This resolution of these
techniques (1 or 2 tm) is limited by inaccurate localization due to scatter from each
radioactive source and the grain size of the photographic film. The duration needed to
expose the photographic film may be inconvenient for certain studies. Tissue sections
have been exposed for up to 308 days to accurately measure low concentrations of
radioiodinated proteins (Schnitzer, Morrel et al. 1987).
II.C.2. Nonradioactive Techniques
Nonradioactive markers such as Evans-blue (Chuang, Cheng et al. 1990),
horseradish peroxidase (Penn, Koelle et al. 1990) and various fluorescent tags, such as
fluorescein isothiocyanate (FITC) (Nakamura and Wayland 1975; Fox and Wayland 1979;
Nugent and Jain 1984; Castellot, Wong et al. 1985; Armenante, Kim et al. 1991), 1,1'-
dioctadecyl 3,3,3',3' tetramethylindocarbocyanine (Dil) (Rutledge, Curry et al. 1990;
Kao, Chen et al. 1995), and rhodamine B (Weinberg 1988), have also been used in
transport experiments. A natural advantage of these labels is the avoidance of
radioactivity. Techniques using nonradioactive markers have often been complicated by
endogenous artifacts and the lack of standard curves to convert measured quantities to
macromolecular concentrations. These markers may also cause the transport of the
labeled macromolecule to differ significantly from the transport of an unlabeled molecule.
This effect is thought to be negligible when a label is relatively smaller than the compound
it is attached to.
The benefits of using a nonradioactive technique to quantify vascular distributions
was demonstrated with the development of a technique using horseradish peroxidase
(HRP), a 40 kD macromolecule, in the rat aorta (Penn, Koelle et al. 1990). This method
utilized the discovery that transmission of light through tissue containing the peroxidase
reaction product was found to be a predictable function of the concentration of the
peroxidase present. Optical magnification provided spatial resolution superior to
measuring profiles of radiolabeled macromolecules by serially sectioning tissues parallel to
the intimal surface. Another benefit was that by fixing exogenous HRP in situ, cellular
and structural features of the tissue were preserved. This technique allowed many
important pharmacokinetic results to be elucidated such as the effect of endothelial cell
injury on the in vivo transport of HRP into the aorta (Penn and Chisolm 1991) and the
permeability of the endothelium and internal elastic lamina (Penn, Saidel et al. 1994).
These studies examined the transport of HRP and it was suggested similar studies could
be done with other macromolecules linked to HRP, but the molecular size of HRP is
comparable to many biologically significant plasma proteins such as albumin (67 kD).
The aqueous tissue processing required to create the reaction product may also cause
post-experiment diffusion of soluble macromolecules.
A description of the fluorescence process is necessary before discussing
fluorescent labels and detection techniques. Fluorescence is the emission of energy by
certain molecules after excitation by an external light source. Molecules possessing this
property are called fluorescent labels or fluorophores. This process is different from
chemiluminescence, where the excited state is the result of a chemical reaction. Energy
from an external source such as an incandescent lamp or a laser is absorbed by the
fluorophore causing it to reach an excited electronic singlet state. The molecule remains in
this excited state for a finite time (-1-10 ns) and after some energy dissipation, may reach
a relaxed singlet excited state, emit a photon of energy, and return to its ground state. The
energy dissipation during the excited-state lifetime decreases the energy, therefore
increasing the wavelength, of the released photon compared to the incident photon. The
release photon is measured usually by either a fluorescent microscope for nonaqueous
phase samples or a spectrofluorometer for bulk phase samples.
Another fluorescent technique which may be used separately or in conjunction
with other techniques is immunohistochemistry, the attachment of fluorescent antibodies
to the compound of interest during post-experimental aqueous processing. Fluorescent
signals can be amplified by repeating the aqueous processing with secondary and tertiary
antibodies that attach to previously attached antibodies. This amplification allows
detection of very small drug concentrations.. Rigorous immobilization of exogenous
compounds in the tissue is needed to prevent soluble compounds to be displaced and
possibly washed away during aqueous processing.
Many different fluorescent tags are used in transport studies with the most
common perhaps being fluorescein isothiocyanate (FITC), a small (389 D), neutral and
polycyclic molecule that is maximally excited at 492 nm and emits energy above 530 nm.
The small molecular size of FITC and the potential for spatial resolution similar to HRP
studies suggest that this marker would be ideal for vascular transport studies. However,
quantitative fluorescence microscopy has been hindered in the past by complications such
as autofluorescence and the proper conversion of measured fluorescent intensities to
physical concentrations.
II.D. Issues with Quantitative Fluorescence Microscopy
Fluorescence microscopy has desirable properties for use in quantifying
compounds in vascular tissue such as providing multi-dimensional information, high
spatial resolution and not depending on aqueous processing. However, autofluorescence
and the proper conversion of fluorescent intensity from fluorophores to physical
concentrations of the compound of interest have limited the use of fluorescence
microscopy in quantitative studies. A review of recent studies which have utilized
advances in computers, digital processing and microscopy suggest that these
complications can be correctly compensated for.
II.D.1. Autofluorescence
Autofluorescence is the phenomena wherein endogenous molecules emit energy in
the same frequency region as introduced fluorescent labels thereby obstructing view of
these labels. The autofluorescence of biomolecules such as elastin, fibronectin and
lipofuscin have been found to be sufficiently broadband and cannot be avoided by
selecting a fluorescent probe with excitation and emission spectra outside the range of
autofluorescent molecules because these spectra are often very broad. Autofluorescence
may be very intense, masking the fluorescent signals of interest. The inhomogeneity of
tissues and autofluorescent molecules often cause this artifact to be highly nonuniform
and difficult to compensate for.
The few reports for reducing or eliminating autofluorescence principally apply to
flow cytometry studies. Different strategies have been suggested to compensate for the
autofluorescence in fluorescence microscopy studies with no standard being adopted.
One strategy that has been used in histological preparations involves counterstaining the
specimen with another compound to quench or absorb the autofluorescence. Crystal
violet has an absorption spectrum that overlaps with the emission spectrum of some
autofluorescent molecules and has been used to quench autofluorescence (Hallden, Skild
et al. 1991; Kong and Ringer 1995), but this technique is not adaptable to fluorescence
microscopy studies.
Time-resolved fluorometry, which utilize the different decay times of
autofluorescent molecules and fluorescent tags, has also been used to compensate for
autofluorescence (Koppel, Carlson et al. 1989). This technique often requires a
sophisticated fluorescence microscope to visualize the time-resolved emission and a
marker such as fluorescent lanthanide chelates which has a long decay time (Seveus,
Viisali et al. 1992). The high cost of the required microscope system and the scarcity of
compounds of interest that are conjugated to these probes may make this method
impractical.
Digital image processing methods have been proposed to reduce and/or eliminate
autofluorescence, first in flow cytometry studies (Steinkamp and Stewart 1986) and then
in histological preparations (van de Lest, Versteg et al. 1995). These post-processing
algorithms were developed after the observation that fluorescent labels have narrower
excitation and emission spectra than the endogenous compounds responsible for
autofluorescence. The autofluorescence at different wavelengths are correlated with each
other and this correlation is used in combination with an image at one wavelength
containing only autofluorescence to estimate the autofluorescence in a corresponding
image at a different wavelength containing both autofluorescence and the signal of interest
from fluorescent markers. The estimated autofluorescence can then be subtracted from
the original image to yield an image whose autofluorescence has been reduced or
eliminated. One advantage of this technique is that a standard fluorescence microscope
with different filter sets is more cost-effective than a microscope with time-delayed
fluorometry capability.
II.D.2. Conversion of Intensities to Concentrations
Fluorescent microscopy is usually used as a binary tool to determine the presence
or absence of a compound by qualitatively assessing the fluorescence from markers
attached to the compound of interest. This method is feasible only if the emitted
fluorescence is much brighter than background. The relation between the fluorescent
intensity from fluorescent tags and the physical concentration of the complex that the tag
is conjugated to is often not quantified. Quantitative analysis requires the development of
a reliable calibration curve to convert fluorescent intensities to physical concentrations of
the compound the label is attached to. The development of an appropriate standard curve
to accomplish this is often the major difficulty when attempting to perform quantitative
fluorescence microscopy. The intensity of various concentrations of a FITC solution in a
hemocytometer (Nakamura and Wayland 1975; Fox and Wayland 1979) or capillary tubes
(Nugent and Jain 1984) has been used to construct a calibration curve. These techniques
have been questioned because the difference in thickness of a section of tissue compared
to a hemocytometer or capillary tube may cause calculated tissue concentrations to not
accurately represent the actual tissue concentration (Armenante, Kim et al. 1991).
II.E. Chapter Summary
Advances in biological and medical research have led to identification of a variety
of compounds that may be of therapeutic value. The administration of these agents is not
straightforward, originally complicated by narrow therapeutic ranges and quick
degradation and clearance. Consistent, sustained release devices remedied these problems,
but further improvements can only be gained by understanding the transport and
deposition within the arterial wall. Current techniques used to assess macromolecular
distributions within the heterogeneous arterial wall have been limited by low spatial
resolution and post-experiment artifact. A new technique to quantitatively assess
vascular drug distributions is needed along with more experimentation to elucidate
macromolecular transport within vessels. Fluorescence microscopy has many desirable
properties for quantifying compounds in tissue, but has not been used previously mainly
due to autofluorescence and difficulties converting fluorescent intensities to physical
concentrations. There appear to be methods to handle these issues and make quantitative
fluorescence microscopy the high resolution technique necessary for future investigation
of macromolecular transport within vascular tissue.
Ill. Quantification of Macromolecular Distributions in
Vascular Tissue
III.A. Introduction
Various mathematical models have been developed to describe macromolecular
pharmacokinetics in the vessel wall (Fry 1985; Saidel, Morris et al. 1987; Penn, Saidel et
al. 1992). The insight gained from these models is directly related to the arterial
concentration profiles used to estimate transport parameters in a model. Current
techniques to quantify macromolecular distributions are inadequate and suggest that new
techniques need to be developed. The limited spatial resolution of some methods forces
characterization of deposition to general, homogeneous compartments which conceals
local concentration gradients in the vessel wall. Other techniques have been complicated
by post-experimental artifact and low signal-to-noise ratios. High resolution
concentration profiles will lead to better pharmacokinetic models and improved
understanding of macromolecular transport and deposition in vascular tissue.
A new method has been developed for visualizing and quantifying macromolecular
distributions in vascular tissue. This technique utilizes fluorescence microscopy with
digital post processing, and avoids the experimental and disposal hazards involved with
radiolabeled compounds while providing spatial resolution comparable to conventional
radioactive techniques. A non-aqueous method to immobilize drug is used to prevent
post-experimental diffusion of soluble molecules, a complication of some previous
techniques. Vessel cross-sections are imaged with fluorescence microscopy, and digital
post processing algorithms are used to reduce autofluorescence, the main complication of
quantitative fluorescence microscopy. Autofluorescence compensation is accomplished
by using images acquired at two different excitation wavelengths, one image containing
both the fluorescence of markers and autofluorescence, and the other image containing
only autofluorescence. The latter image is then used to estimate the autofluorescence in
the former image. This estimated autofluorescence can then be subtracted from the former
image to yield an autofluorescence-free image containing only the signal from the
fluorescent tags. Fluorescent intensities are then converted to tissue concentrations after
autofluorescence compensation, yielding a two-dimensional, high resolution
macromolecular distribution within a vessel cross-section. A demonstration of this
technique examining the transvascular transport of dextrans in the calf carotid artery is
shown. This technique can be used to investigate the pharmacokinetics of different
compounds to provide the quantitative data necessary to evaluate transport models and
gain insight into the transport of administered agents as well as elucidate details of blood
vessel physiology, homeostasis, and pathology.
IlI.B. Materials and Methods
III.B.1. Calibration Standards
Calf carotid arteries were obtained from a slaughterhouse (Research 87) and stored
on ice for no more than two hours. The arteries were placed in phosphate buffer saline
with calcium and magnesium (PBS" ) throughout the preparation process to prevent
dehydration and maintain tissue viability. Excess fascia and fat was gently teased away
using forceps and scissors prior to sectioning vessels into cylindrical rings, 8-12 mm long
and 4-8 mm in diameter. These rings were placed into separate vials containing 10 ml of
known concentrations of 20 kD dextrans labeled with fluorescein isothiocyanate (FITC-
Dx, 0.006-0.007 mol FITC per mol glucose, Sigma) in PBS++. Control specimens were
incubated in 10 ml PBS without any FITC-Dx. The vials were wrapped with aluminum
foil to prevent photobleaching of the fluorescent labels from extraneous light, and
incubated at 4' C in the dark for 24 hours before immobilization.
III.B.2. Immobilization and Sectioning
Tissues were snap frozen immediately after removal from an incubation vial.
Arteries were placed in plastic molds (Polysciences) and oriented for future sectioning
with forceps. The mold was then filled with embedding medium (O.C.T., Tissue-Tek)
and placed in a bath of liquid nitrogen to solidify the medium. Specimen blocks were
stored at -20 'C prior to being cut into 20 gm thick cross-sections using a precooled
cryostat (Ames Cryostat II, Miles). Frozen medium around the tissue was gently
removed to facilitate mounting onto slides. Specimens were transferred onto glass slides
(Superfrost Plus, VWR Scientific), freeze dried at -50 OC in a lyophilizer (Labconco) for
24 hours, and stored at room temperature in a dark, dry environment until imaging.
III.B.3. Image Acquisition System
24-bit color images were acquired using a CCD video camera system (Optronics)
attached to a fluorescence microscope (Optiphot-2, Nikon). The system resided on a
pneumatic optical table (Technical Manufacturing Corporation) to minimize vibrations.
Video images were captured on a computer (Power Computing) via a frame grabber (LG-
3, Scion) using a commercial imaging software package (IPLab Spectrum, Signal
Analytics). The frame grabber was calibrated by displaying a test image consisting of
color bars generated from the video camera system. The gain and offset of the frame
grabber were adjusted to match its dynamic range (0 to 255 units for the red, green and
blue channels) to the dynamic range of the video camera system. Magnification was
provided by a x10 ocular and a xlO objective, resulting in 640 by 480 pixel images with
pixel dimensions of 1.326 Cim by 1.326 nm. Illumination was provided by a super high
pressure mercury lamp (Nikon) which was allowed to warm up for at least 2 hours prior
to imaging for consistent illumination. The duration needed for the lamp to stabilize was
determined by imaging a blank slide at various intervals after the system was turned on.
The mean intensity of a 51 by 51 pixel region in the center of the image was found to
stabilize after 2 hours. UV and FITC filter sets were used to examine tissue specimens.
The UV filter set consisted of an excitation filter of 330-380 nm, a dichroic filter
(beamsplitter) of 400 nm and a barrier filter of 420 nm, and the FITC filter set consisted
of an excitation filter of 465-495 nm, a dichroic filter of 505 nm and a barrier filter of 515-
555 nm. The fluorescent tag used in these experiments, fluorescein isothiocyanate
(FITC), is maximally excited around 490 nm so UV images contain only autofluorescence
and FITC images contain both autofluorescence and signal from the fluorescent labels.
Hence forth, UV and FITC images refer to images taken with the UV and FITC filter sets,
respectively.
III.B.4. Initial Processing
Images were acquired using RGB (red, green, blue) color components and
converted to the HSV (hue, saturation, value) color model. The HSV color model
decouples intensity from color information in an image, with the value image containing
intensity and the hue and saturation images containing color information. Both UV and
FITC images were decoupled in this manner and the hue and saturation images were
discarded (step 1 in Figure 2). The remaining intensity value image has intensity values
range from 0 (absolute black) to 255 (absolute white).
This study focused on obtaining concentration profiles across the media, the
middle layer of the artery between the intima and adventitia, since many vasotherapeutic
compounds target smooth muscle cells in the media. Similar processing can be used to
examine other layers of the artery. A 51 pixel wide region of each image was selected for
analysis that spanned across the media (step 2 in Figure 2). Hence forth, UV and FITC
regions will refer to the extracted region corresponding to the media in the UV and FITC
images, respectively. These regions were then corrected for autofluorescence.
III.B.5. Autofluorescence Compensation
Since UV images contain only autofluorescence and FITC images contain both
autofluorescence and the signal of interest, each pixel in a UV image can be used to
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Figure 2. Post processing algorithm to compute concentration
profiles. The top two color images are fluorescent images of a
cross-section of a calf carotid artery imaged with the FITC and
UV filter sets, respectively. (1) The intensity subimage of
each color image is extracted. (2) A region corresponding to
the media is extracted from each intensity subimage. (3) The
UV region is used to estimate autofluorescence in the FITC
region. (4) The estimated FITC autofluorescence is subtracted
from the FITC region, yielding only the signal from
fluorescent labels. (5) Pixel intensities are converted to tissue
concentrations resulting in a two-dimensional concentration
profile of fluorescent labeled compounds within the tissue.
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estimate the autofluorescence in the corresponding pixel in the counterpart FITC image.
Corresponding pixels from the UV and FITC regions of a control specimen were
correlated, yielding a relationship which allows the estimation of the autofluorescence
component in each pixel of a FITC region using the corresponding pixel in the counterpart
UV region (step 3 in Figure 2). This estimated autofluorescence is then subtracted from
the original FITC image yielding an autofluorescence compensated FITC image that
contains only the signal from fluorescent markers (step 4 in Figure 2).
III.B.6. Conversion of Fluorescent Intensities to Tissue Concentrations
Fluorescent intensities were converted to tissue concentrations using a standard
curve obtained from specimens incubated until equilibrium in known concentrations of
FITC-Dx in PBS + . The average fluorescent signal in an autofluorescence compensated
FITC region of a specimen was correlated with the bulk phase concentration of FITC-Dx
in PBSf+ the specimen was incubated in. This allowed fluorescent intensities to be
converted to bulk phase concentrations. Compounds in bulk solutions are free to access
any portion of a unit volume of solution. In contrast, compounds in tissue are excluded
from certain regions of a unit volume by steric interactions. The volume accessible is a
fraction of the total tissue volume and this fractional tissue volume is needed to convert
bulk phase concentrations to tissue concentrations. An independent measurement
correlating bulk phase concentrations and tissue concentrations gives the fractional
volume of the tissue available for compound distribution. The two previous relations can
then be combined to convert the fluorescent intensity of every pixel in an
autofluorescence compensated FITC images to a tissue concentration of FITC-Dx in
PBS++ (step 5 in Figure 2). Applying this relation to the autofluorescence compensated
FITC region yields a two-dimensional concentration profile of the vessel cross-section.
III.B.7. Equilibrium Time for Standards
The use of calibration standards to convert fluorescent intensities to drug
concentrations requires standards that are incubated until the tissue is at equilibrium with
the bulk incubation solution. The incubation time required for standards to reach
equilibrium was determined by incubating cylindrical segments of calf carotid arteries in
10 ml of 1 mg/ml FITC-Dx in PBS ++ at 4° C for durations ranging from 1 hour to 48
hours. After the incubation period, each tissue section was blotted to remove adsorbed
solution, weighed wet and reincubated in 10 ml of fresh PBS at 4° C for 48 hours to
allow the drug to diffuse out of the tissue. Samples of the reincubation solution were
measured with a spectrofluorimeter (Fluorolog 1681, SPEX). The resulting fluorometric
counts per second were converted to bulk solution concentrations using a standard curve
created with known concentrations of FITC-Dx in PBS'.
This bulk phase reincubation concentration of FITC-Dx in PBS + (C2) can then
be used to calculate the original tissue concentration of FITC-Dx in PBS " (CT) with the
following formula which is derived in the Appendix:
CVp
x
where V is the volume of the reincubation bath volume, p is the density of tissue, and x
is the wet tissue weight. In separate experiments, the density of calf carotid arteries (p)
was measured to be 1.07 ± 0.096 mg/ml (n=15) using a micro-graduated cylinder and an
analytical balance. It was determined that 24 hours was sufficient for the tissue sections
to reach equilibrium with the FITC-Dx solution (Figure 3).
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III.B.8. Demonstration
To demonstrate the utility of this technique, arterial concentration profiles were
constructed from calf carotid arteries that were placed in an in vitro perfusion apparatus
designed to simulate plasma flow. A schematic diagram of the apparatus is illustrated in
Figure 4. Excess fascia and fat from calf carotid arteries were removed as described in the
Materials and Methods section and artery segments without visible branches were then
cannulated at both ends and tested for leaks by visually inspecting the vessel after
connecting one end to an elevated Ringer's solution source and closing off the other end.
Intact arteries were then placed in a perfusion apparatus which has separate endovascular
and perivascular compartments which allow establishment of a transvascular
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Figure 3. Tissue concentration as a function of incubation
time (mean ± standard deviation, n = 3). The tissue
concentration of calf carotid artery sections were measured
after incubation in 1 mg/mi FITC-Dx in PBS" for different
durations. The dashed line designates the tissue concentration
at equilibrium (0.60 mg/ml) which is achieved in less than 24
hours.
concentration gradient. Arteries were perfused with an endovascular bath of 1 mg/ml
FITC-Dx in PBS+ and a perivascular bath of PBS ++ at room temperature. There was no
transvascular pressure gradient across the vessel, so any transport would be due solely
due to diffusion. Specimens were immediately snap frozen, sectioned, imaged, and
digitally post processed as described previously. Vessel cross-sections were oriented
during imaging so that regions could be extracted which could be averaged across each
column to obtain a transvascular concentration profile.
Ill.C. Results
III.C.1. Autofluorescence Compensation
UV and FITC images of control arteries were examined to correlate the
autofluorescence at the UV and FITC wavelengths. Figure 5 shows a scatter diagram of
It'
Figure 4. Schematic diagram of in vitro perfusion apparatus.
pixel intensities in a UV region of a control artery versus the corresponding pixel
intensities in the FITC region along with a linear fit to the intensities. The linear
relationship allows the estimation of the autofluorescence component in each pixel of
other FITC images using the corresponding pixel in the counterpart UV image:
FITC(autofluorescence) = A *UV(total) + B
where A = 0.073 and B = 44.94. The estimated autofluorescence can then be subtracted
from the original FITC image yielding the signal of fluorescence markers alone:
FITC(specific) = FITC(total) - FITC(autofluorescence)
= FITC(total) - (A *UV(total)+B)
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Figure 5. Correlation between UV and FITC autofluorescence.
The media of a control artery was extracted after being imaged
with the FITC and UV filter sets. Pixel intensities in the FITC
image are plotted as a function of the intensity of the
corresponding pixel in the counterpart UV image. The linear
fit can be used with a UV image to estimate the
autofluorescence in the corresponding FITC image.
III.C.2. Conversion of Fluorescent Intensities to Tissue Concentrations
The conversion of fluorescent intensities to tissue concentrations requires two
relations. The first is the relation between fluorescent intensities and bulk phase
concentrations of calibration standards, specimens incubated until equilibrium in known
concentrations. The range of this mapping is bounded by two factors. The lower
concentration bound is determined by the sensitivity of the image acquisition system, and
low fluorescent emissions from dilute concentrations of the fluorescently labeled drug.
The upper concentration bound is determined by saturation of the image acquisition
system. Figure 6 shows the mean region intensity plotted versus the bulk phase
incubation concentrations of FITC-Dx in PBS " and a semilog curve fit to the data.
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Figure 6. Fluorescent intensity as a function of incubation
concentration (mean ± standard deviation, n = 3). Arteries
were incubated in different concentrations of FITC-Dx in
PBS"+, and the mean intensity of a 51 by 51 pixel region
corresponding to the media in the autofluorescence
compensated images was calculated. The correlation can be
used to convert fluorescent intensities to macromolecular
concentrations.
~,,,,~.~.~..~....~~.~,~r mr m, m .,mm.ml- mm..,rm, m,, Im-, r , m r r ,
,,","",,,,,""mmm"""m,""""mmmr- -- -- -
As described above, autofluorescence was compensated before constructing this
relationship. The data show that bulk phase concentrations ranging over two orders of
magnitude (0.02 mg/ml to 2.5 mg/ml) can be reconstructed by inverting the curve fit to the
data.
The second relation needed to convert fluorescent intensities to tissue
concentrations is the fraction of tissue volume available to a compound. The fractional
tissue volume was determined by examining cylindrical sections of calf carotid arteries
incubated in 10 ml of different concentrations of FITC-Dx in PBSf+ for 24 hours. As
shown earlier, this time is sufficient to reach equilibrium (Figure 3). Tissue
concentrations were computed as described in the Appendix. Figure 7 shows tissue
concentration plotted versus bulk phase concentrations of FITC-Dx in PBS ++ in
calibrations samples that were incubated from 0.5 mg/ml to 1 mg/ml.
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Figure 7. Tissue concentration as a function of bulk phase
concentration (mean ± standard deviation, n = 3). Calf carotid
artery sections were incubated in different bulk concentrations,
and the tissue concentration was measured at equilibrium. The
ratio of tissue concentration to bulk phase concentration is an
estimate of the fractional volume available for distribution
within the tissue.
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The slope of the linear correlation between bulk phase and tissue concentrations is the
fractional tissue volume available to FITC-Dx. This fractional volume allows bulk phase
concentration to be converted to tissue concentrations.
III.C.3. Demonstration
Figure 8 shows transvascular concentration profiles obtained for arteries that were
perfused for 60, 90, and 120 minutes with no transvascular pressure gradient, an
endovascular bath of 1 mg/ml FITC-Dx in PBS +" and a perivascular bath of PBS" at
room temperature. A one-dimensional transvascular profile was obtained by averaging
across the width of the two-dimensional FITC region obtained after applying the post
processing algorithm described earlier.
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Figure 8. Transvascular concentration profiles. Arteries were
perfused for 60, 90, and 120 minutes with no transvascular
pressure gradient, an endovascular bath of 1 mg/ml FITC-Dx
in PBS" and a perivascular bath of PBS " at room temperature.
The transvascular concentration profiles were obtained using
the quantitative fluorescent microscopy technique developed in
this work.
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III.D. Discussion
A new technique has been developed to obtain arterial concentration profiles
combining fluorescence microscopy and post processing. The use of fluorescence
microscopy offers several advantages over other techniques that have been developed to
quantify arterial concentrations of compounds, but also introduces additional issues such
as autofluorescence and the conversion of fluorescent intensities to physical
concentrations.
III.D.1. Comparison with Other Techniques
Vascular deposition studies have utilized radioactive nuclides which minimally
change the physical structure of a compound and its transport properties, but these
experiments often have limited spatial resolution and experimental and disposal hazards.
Early studies measured the radioactivity in manually dissected sections providing
questionable repeatability as well as limited spatial resolution (Duncan, Buck et al. 1963).
Measuring radioactivity in en face serial sections, sections parallel to the intimal surface,
provides resolution of 10-20 im and can only assess the macromolecular distribution in
one orientation (Bell, Adamson et al. 1974; Bell, Gallus et al. 1974; Bratzler, Chisolm et
al. 1977; Bratzler, Chisolm et al. 1977; Ramirez, Colton et al. 1984; Tedgui, Merval et al.
1992). The radiolabeled drug content in a specimen can also be visualized by allowing the
specimen to develop specially prepared photographic film or an emulsion silver
preparation. The density of exposed silver grains can then be quantified by silver grain
counting or optical density methods. These autoradiographic techniques offer increased
resolution (up to -2 gm), but may be hampered by inaccurate localization, the grain size
of the photographic film, inconsistent background radiation and/or post-experimental
diffusion of soluble macromolecules in the emulsion silver preparation (Aitken, Wright et
al. 1968; Fry, Mahley et al. 1980; Schnitzer, Morrel et al. 1987; Tompkins, Yarmush et
al. 1989). The duration needed to expose the developing film or emulsion preparation
may also be inconvenient.
Nonisotopic techniques include biochemical and fluorescent labels. They offer
higher spatial resolution and avoid the hazards of radioactivity, but may be limited by
marker sizes, which affect the physicochemical properties of labeled macromolecules.
The transport of horseradish peroxidase (HRP) has been quantified in arteries using a
colored reaction product whose intensity was a function of the concentration of HRP
(Penn, Koelle et al. 1990). Specimens were examined with a light microscope which
provided HRP concentration profiles with spatial resolution superior to radioactive
techniques. Similar studies with vasotherapeutic compounds would greatly aid drug
delivery research, however, this technique has not been adapted to study vasoactive
compounds. The large size of HRP (40 kD) prevents its utility as a molecular tag on
much smaller drugs. In addition, the aqueous tissue processing required to create the
colored reaction product may also cause post-experiment diffusion. Fluorescence
microscopy offers the advantage of obtaining high spatial resolution data as in HRP
studies, using smaller sized marker (e.g. the common fluorescent tags, FITC and
rhodamine isothiocyanate, are -400 D) and does not require aqueous tissue processing.
Quantitative studies, however, have been complicated by autofluorescence and the proper
conversion of fluorescent intensities and drug concentrations. However, methods have
been developed to minimize these complications.
III.D.2. Autofluorescence Compensation
Constituent arterial components such as elastin, fibronectin and lipofuscin, exhibit
autofluorescence, the emission of energy in the same frequency region as exogenous
fluorescent labels (van de Lest, Versteg et al. 1995). The fluorescence spectra of these
compounds are very broad and the autofluorescence cannot be avoided by selecting a
probe with excitation and emission spectra outside their range. Autofluorescence may be
very intense, masking the fluorescent signals of interest and the inhomogeneous
distribution of autofluorescent molecules often cause this artifact to be nonuniform and
difficult to compensate for. Attempts to eliminate background autofluorescence by
counterstaining connective tissue with compounds such as crystal violet (Hallden, Skild
et al. 1991) or pontamine sky blue (Cowen, Haven et al. 1985) derived from flow
cytometry applications may not be suitable because such aqueous tissue processing may
result in post-experimental diffusion of the drugs.
Time-resolved fluorometry, which utilizes the different decay times between
autofluorescent molecules and fluorescent tags, has also been used to compensate for
autofluorescence (Koppel, Carlson et al. 1989; Marriott, Clegg et al. 1991). In addition to
requiring a sophisticated fluorescence microscopy system, this technique may require
special fluorescent tags such as lanthanide chelates (Seveus, Vaiisdli et al. 1992), which
may not be readily available individually or conjugated to compounds of interest.
After the observation that fluorescent labels have narrower excitation and emission
spectra than the endogenous compounds responsible for autofluorescence, digital image
processing methods have been developed to reduce and/or eliminate autofluorescence, in
flow cytometry studies (Steinkamp and Stewart 1986) and in histological preparations
(Sz6ll6si, Lockett et al. 1995; van de Lest, Versteg et al. 1995). Images were captured at
two wavelengths with one image consisting only of autofluorescence, and the other image
possessing both autofluorescence and the fluorescence signal of interest. The former
image is then be used to estimate the autofluorescence in the latter image. Assuming that
autofluorescence and the fluorescence from the labels are simply additive components, the
estimated autofluorescence is then subtracted from the latter image to yield an
autofluorescence compensated image with signal only from the fluorescent probes. The
main advantage of this technique is that it is simple to implement. A disadvantage of this
technique is that different tissue types may need to be compensated separately because
the function used to estimate the autofluorescence at one wavelength using the
autofluorescence of another wavelength is probably different for different tissues.
III.D.3. Conversion of Fluorescent Intensities to Tissue Concentrations
Fluorescent microscopy is usually used as a binary tool to determine the presence
or absence of a compound by qualitatively assessing the fluorescence from markers
attached to the compound of interest. The relation between the fluorescent intensity
from fluorescent tags and the tissue concentration of the compound that the tag is
conjugated to is often not quantified. Quantitative analysis requires the development of a
reliable calibration curve to convert fluorescent intensities to physical concentrations.
Calibration curves have been constructed by measuring the intensity of various
concentrations of a FITC solution in a hemocytometer (Nakamura and Wayland 1975;
Fox and Wayland 1979) or capillary tubes (Nugent and Jain 1984) to obtain a calibration
curve. As pointed out by Armenante et al. (1991), the difference in thickness of a section
of tissue compared to a hemocytometer or capillary tube may cause calculated tissue
concentrations to not accurately represent the actual tissue concentration. To date, there
has been no attempt to create standard curves for fluorescent compounds in arteries using
the identical tissue for both experimentation and calibration. This was accomplished in
this study by incubating tissue in different concentrations until equilibrium. These
calibration standards were then used to construct a relationship between fluorescent
intensity and bulk phase concentration. Bulk phase concentration can then be converted
to tissue concentration by measuring the fractional volume available to the particular
compound.
III.D.4. Future Applications
The examples shown here demonstrate the potential of this technique for
providing high resolution concentration profiles. Note that higher magnification could
have been used for higher spatial resolution, but this magnification allows the entire width
of a calf carotid artery to be captured onto a single image. Since this technique is
adaptable to studies with different compounds, one could perform similar studies with
compounds of slightly differing physicochemical properties. These studies would show
the relative importance of physicochemical properties such as size, charge, solubility, and
flexibility on the transport and deposition of compounds through the arterial wall.
Dextrans would be ideal for these experiments since fluorescently labeled dextrans are
readily available with different molecular weights. Amino and sulfide groups could also
be conjugated to examine the effect of charge on transport. By combining data from these
experiments, a model could be constructed to predict the transport of a compound based
solely on its physicochemical properties.
III.E. Chapter Summary
Biomedical research continues to elucidate details about the pathobiology of many
diseases leading to the development of new therapeutic agents. The therapeutic potential
of these pharmacological agents has been confounded by an inability to describe
macromolecular distributions within the heterogeneous arterial wall which has led to
inadequate understanding and modeling of the pharmacokinetics of compounds following
administration. Quantitative tools to assess vascular distributions of macromolecules
need to be developed to provide high spatial resolution distribution profiles. These
profiles will allow quantitative pharmacokinetic models to be evaluated, resulting in
improved understanding of solute transport through the vessel wall and development of
better vascular pharmacokinetic models. This work describes a quantitative fluorescence
microscopy technique which is made possible by digital post processing to eliminate
autofluorescence and convert fluorescent intensities to drug concentrations. This
technique offers spatial resolution comparable to conventional radioactive techniques and
is adaptable to fit many experimental protocols. In addition to aiding the evaluation and
rational design of drug delivery strategies, this technique can be a valuable tool for
investigation into the pharmacology and physiology of the vessel wall.
IV. Measurement of Transvascular Transport
Parameters
IV.A. Introduction
A new method utilizing quantitative fluorescence microscopy with digital post
processing to measure vascular tissue concentrations was described in the last chapter.
This technique was developed after determining that previous methods used to assess
vascular distributions were inadequate for studying macromolecular transport in the
vessel wall. This chapter describes the integration of this new technique with in vitro
experiments and mathematical modeling to estimate transport parameters such as effective
diffusivity, convective velocity and endothelial permeability. These transport parameters
can then be used to construct detailed mathematical models that predict macromolecular
distributions under different conditions. These models will be of great utility to drug
delivery research as they provide a method to test the feasibility and efficiency of
different drug delivery schemes without actually performing in vivo experiments.
The transport of 20 kD dextrans (polymers constructed using a glucose monomer)
labeled with fluorescein isothiocyanate (FITC) in calf carotid arteries were examined in an
in vitro perfusion apparatus which simulates plasma flow. These experiments were
performed for different durations with varying transvascular pressure and concentration
gradients. Perfused arteries were processed using the technique developed in the previous
chapter. Arterial concentration profiles are extracted from the fluorescence microscopy
images and fitted to a mathematical model of transvascular transport. The transport
parameters obtained from these experiments can then be used to simulate the transport
and deposition of 20 kD dextrans under different conditions. Preliminary results are
shown to demonstrate the feasibility and potential of these proposed experiments.
Dextrans were chosen as the model compound for these studies because they are
inexpensive and readily available with fluorescent tags conjugated to them. The use of
- m
dextrans is also advantageous because their physico-chemical properties are easily
modifiable. For example, amino and sulfide groups can be attached to alter its charge and
different sized dextrans can be obtained simply by constructing smaller or longer polymer
units. Future experiments using similar dextrans could be compared to isolate the effects
of different physico-chemical properties on a compound's vascular pharmacokinetics.
These experiments will lead to a better understanding of solute transport and deposition
in the vessel wall which can then be applied to improve drug delivery.
IV.B. Mathematical Modeling
Many different mathematical models of transvascular transport have been
proposed by different investigators (Fry 1985; Saidel, Morris et al. 1987; Penn, Saidel et
al. 1992). Transport studies have usually assumed circumferential and longitudinal
symmetry and modeled transvascular transport due to the complex nature of multi-
dimensional transport, and lack of circumferential and axial deposition data. Lumped
kinetic models were developed to quantify macromolecular uptake (Duncan, Cornfield et
al. 1959). In these early models, the artery and plasma are represented as individual, well
mixed components with transport between them governed by first order transport
kinetics. These models are limited because their empirical nature provides little insight
into the mechanisms of solute transport within the artery. Another approach is to depict
the arterial wall as an infinite number of concentric and infinitesimally thin homogeneous
compartments (Lovich and Edelman 1996). Since these distributed or continuum models
describe the tissue concentration in the vessel wall continuously, local changes in
transport are evident as concentration gradients. Transport parameters are obtained by
fitting measurements of arterial concentration profiles to a theoretical model of vascular
transport. These parameters quantitatively describe transport within the vessel wall, and
can be used to simulate the effect of different loading conditions.
The model used in this study is similar to one used to analyze dynamic
transvascular macromolecular concentrations of horseradish peroxidase as a function of
time and radial distance from the internal elastic lamina (IEL) (Penn, Saidel et al. 1992). In
this model, the endothelium and IEL are assumed to act as an infinitesimally thin
endovascular "membrane" with transport characterized by a permeability (Pndo ).
Similarly, the adventitia is considered to be a infinitesimally thin perivascular membrane
with permeability (P,,,i). Both of these membranes can also be defined in terms of their
resistance, the inverse of permeability. The model assumes the media is homogeneous
and solute transport across the media is assumed to occur only by diffusion or
convection. The random collision of macromolecules driven by transvascular
concentration gradients results in diffusion, quantitatively described by an effective
diffusivity (D). A transvascular pressure gradient and the porosity of an artery result in
convection, the transport of solutes in fluids being driven across the vessel wall,
characterized by a convective velocity (V). Another parameter that must be defined is
the fraction of the tissue space available for macromolecular distribution (E). (Note that
0 E 1.) This parameter allows concentrations in the model to be expressed per
volume of wet tissue and defines the relation between these tissue concentrations to bulk
phase concentrations (such as the endovascular and perivascular bath concentrations)
which are expressed per volume accessible to a compound.
The basic equation of transvascular transport has diffusion mediated and
convection-borne terms and can be expressed as
dC(x, t) C(, t) dC( t) < x < L
dt d&2
where C(x, t) is the concentration distribution of a macromolecule in the media as a
function of radial distance x from the IEL and time t, and L is the thickness of the
media. The boundary conditions are
D t) Pendo Cend(t) + VC(xt) x = 0dxI EI
D dC(x = -Pperi C(xt)Cperi(t) + VC(x, t) x= L
and the initial condition is
C(x,t)=O t<O.
where Cendo(t) and Cperi(t) represent the endovascular and perivascular bulk phase
concentrations as functions of time t, respectively. (The basic equation and boundary
equations are derived from first principles in the Appendix.)
Other models have included effects not represented in this model such as
reversible binding, dissociation, and intracellular degradation. These were not included in
this analysis because fitting models with many parameters to a single concentration
profile may lead to a mathematically underconstrained problem, i.e., a problem with too
many degrees of freedom. This can lead to multiple solutions that fit the data with the
same accuracy that depend on the initial parameter estimates used to start the fitting
algorithm. It is then difficult to distinguish the "true" solution from other solutions. To
reduce the possibility of these numerical complications, the model used incorporates only
those mechanisms that appear to be dominant in the solute transport of dextrans. The
effects not included in the model described may also be included in later analysis for a
more complete model, one that contains more potential transport mechanisms.
IV.C. Perfusion Experiments
The transvascular transport of fluorescently labeled 20 kD dextrans in the calf
carotid artery was examined using an in vitro perfusion apparatus that simulates plasma
flow. Excess fascia and fat from calf carotid arteries was removed as previously
described. A 15-25 mm artery segment without visible branches was then cannulated at
both ends and tested for leaks by visually inspecting the vessel after connecting one end
to an elevated lactated Ringer's solution source (Baxter) and closing off the other end.
Intact arteries were placed in the perfusion apparatus for different durations. In addition
to separate endovascular and perivascular compartments which allow establishment of a
transvascular concentration gradient, the apparatus can simulate plasma flow with varying
pressure gradients. The perfusate flows from an upper reservoir through the artery,
empties into a lower reservoir, and is pumped back to the upper reservoir with a
hydrostatic pump. The height of the upper reservoir can be adjusted to establish a fixed
transvascular pressure gradient and a separate reservoir for the perivascular bath allows
establishment of transvascular concentration gradients. Perfusions were done at room
temperature and the entire apparatus was enclosed in a wooden cabinet to prevent
photobleaching of any fluorescent molecules.
This section describes a set of experiments to elucidate the vascular
pharmacokinetics of 20 kD dextrans in the calf carotid artery. A similar experimental
protocol utilizing this in vitro perfusion apparatus has been successful for investigating
heparin transport in the rat abdominal aorta (Lovich and Edelman 1995). Dextrans should
be placed either in the endovascular or perivascular bath, but not both, to separate the
effects of transmural transport in each direction and simplify mathematical modeling. The
last chapter showed that bath concentrations between 0.02 mg/ml to 2.5 mg/ml are
necessary for the fluorescent signals be detectable. Therefore, 1 mg/ml can be used for the
bath containing dextrans. Further investigation using 0.5 mg/ml may provide insight into
mechanisms more dependent than convection and diffusion on absolute concentration
such as binding and internalization. Convection is easily examined by applying no
transvascular pressure gradient or a fixed value such as 100 cm to simulate a physiological
pressure gradient. Multiple time points are necessary to estimate temporal aspects of a
mathematical model. Einstein's solution to the one-dimensional Fick equation (F2 = 2Dt,
where F2 is the mean-squared displacement a diffusing particle with effective diffusivity
D travels after time t) suggest that experiments should be performed with durations that
are separated by factors of 4 to allow temporal discrimination. Therefore, arteries could
be perfused for 15 minutes, 1 hour, or 4 hours. Preliminary experiments shown in this
chapter examined a small subset of the proposed experiments. Arteries were perfused for
one hour using an endovascular bath of 1 mg/ml of 20 kD FITC-Dx in PBS"+ , and
perivascular bath of PBS+". There was no transvascular pressure gradient in these
preliminary experiments, so any transport would be due solely to diffusion.
IV.D. Extraction of Concentration Profiles from Images
Perfused arteries were then processed using the procedure documented in the
previous chapter. Transvascular concentration profiles were extracted with a user-
assisted algorithm which prompts the user to delimit a 21 pixel thick region of media from
the internal elastic lamina to the media-adventitia border. In anticipation of the extraction
of the media, arterial cross-sections were oriented during imaging so that rectangular
regions could be used to delimit the media. The 21 pixel thick region was averaged, giving
a one-dimensional transvascular concentration profile. To reduce experimental variance,
transvascular concentration profiles were constructed from five different cross-sections of
the same artery and averaged with the average profile being truncated to the length of the
shortest profile. Other studies have utilized a normalized distance from the endothelium
with the distance of each point in the profile divided by the length of the media, resulting
in distances ranging from 0 (the endothelium) to 1 (the media-adventitia border) (Bratzler,
Chisolm et al. 1977; Ramirez, Colton et al. 1984; Penn, Koelle et al. 1990). This
approximation may not be significant if the extracted media from cross-sections of the
same artery have similar lengths. The procedure used in these studies did not use this
approximation in an effort to maintains the spatial accuracy of individual profiles.
Two issues complicate the extraction of transvascular concentration profiles from
two-dimensional images. The first is the inherent asymmetry of biological tissue which
may cause substantial variability between profiles obtained from different transvascular
regions of the same specimen. This complicates the process of averaging specimens to
reduce experimental noise and suggests the need to image the identical transvascular region
of different cross-sections when imaging. One possible solution would be to place
fiduciary marks on the specimen block before sectioning. The other issue is the difficulty
discerning the edges of the media when extracting it from the artery. The media was
extracted by a human operator using the UV image since the internal elastic lamina and
adventitia tend to have greater fluorescence than the media in this image. After the user
acquires some experience with extracting the media, this criteria is adequate for gross
characterizations but may be inaccurate at the pixel level which has micron resolution
with this technique. This is significant because fitting parameters such as the
endovascular and perivascular permeabilities are heavily dependent on points near the
boundaries of the delimited media.
IV.E. Determination of Transport Parameters
Transport parameters are determined by fitting a mathematical model of transport
to measured concentration profiles. This procedure is not straightforward since the
distributed model formulated earlier is described by partial differential equations and a
function of continuous time and space, and each concentration profile is discrete in space
and sampled at one instance in time. The method chosen in this study is to fit the
concentration profile to simulations of the distributed model using finite difference
approximations in space and Euler integration in time. A discrete concentration profile
was simulated at evenly-spaced points throughout the media (x,,..., XN). The
endovascular and perivascular baths are assumed to be of constant concentration
throughout the experiment:
Cendo(t) = Co
Cperi (t) = C1
and with no prior loading of the artery with dextrans, the initial conditions at each node
are:
C(x,, 0) = O, i = 1,...,N
Derivatives with respect to time in the governing transport equations were estimated by
finite difference approximations:
dC(xi, t) C(x, , t) - C(x 1 , t)
dx Ax
9C 2 (xi t) C(xi+1 , t) - 2C(x , t) + C(x,_, t)
dX2  (Ax) 2
where Ax represents the distance between two nodes xi and xi,, in the media. The
distribution in the artery was then simulated by Euler integration in time:
dC(x,t) i ,
C(x, txj = Cx, 2 ) + At ,x i = I,..., N
St) +At DC(xi+l ti) - 2C(x,, tj) + C(xiI ti) -C(x tj) - C(xI, t )
i = 1,...,N
where At represents the increment (difference) between two time points tj and tj+,
during Euler integration.
The transvascular transport model discussed in the previous section was
implemented using MATLAB (MathWorks), a commercial programming language. The
MATLAB program was then combined with a Nelder-Meade function-minimization
routine to solve for transport parameters using an error criterion of the mean-square error
between the experimental and simulated concentration profiles at each node. Model
parameters are defined to be positive with no physical meaning otherwise. These
positive restrictions were implemented by assigning a large error (10,000) to any profile
obtained during parameter searches with negative parameters. Since the dimensions of
each pixel are 1.326 um by 1.326 um and the thickness of the media of a calf carotid
artery is approximately 400 um, approximately 300 nodes would have to be used if every
pixel is fit to a node. Preliminary studies showed that if the number of nodes was equal
to the number of pixels needed to span the media, the computation time required for
fitting would be prohibitive. Note that the parameter fitting routine must calculate the
concentration at each node at every time increment during Euler integration. To reduce
computation time, 40 nodes were defined across the media and the concentration at each
of these nodes was simulated. The corresponding concentration at each node of the
experimental profile was then obtained by linear interpolation of the measured profile,
and the mean-square error was computed using this interpolated profile and the simulated
profile. One second was used as the time increment for Euler integration which was
determined by using the largest increment possible without visible numerical instabilities.
With the assumptions and approximations described above, there are five
transport parameters that need to be estimated in the parameter fitting routine:
D, Pendo Pperi, E, and V. There are many practical issues involved with fitting
experimental data to transport parameters in a mathematical model and this area needs
further exploration. Preliminary experiments were done without transvascular pressure
gradients, so the convective velocity (V) can be set to zero. The fraction of tissue space
that 20 kD dextrans can distribute in the media was determined in the equilibrium studies
described in the last chapter (Figure 7), so this parameter (E) was fixed at 0.5233. This
leaves three unknown parameters, the effective diffusivity and the endovascular and
perivascular permeabilities, that need to be fitted.
Transport parameters were computed from transvascular concentration profiles of
calf carotid arteries that were perfused for one and two hours at room temperature with
no transvascular pressure gradient, and endovascular bath of 1 mg/ml FITC-Dx in PBS+"
and a perivascular bath of PBS' at room temperature. Figure 9 illustrates measured and
simulated transvascular concentration profiles of arteries that were perfused for one hour,
and Table 1 shows the initial and final parameter values and mean-square errors of the
parameter fitting routine. Figure 10 illustrates measured and simulated transvascular
concentration profiles of arteries that were perfused for two hours, and Table 2 shows the
initial and final parameter values and mean-square errors of the parameter fitting routine.
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Figure 9. Concentration profiles for one hour perfusion data.
Arteries were perfused for one hour with no transvascular
concentration gradient, an endovascular bath of 1 mg/ml of
FITC-Dx in PBS" and a perivascular bath of PBS". The
measured concentration profile was then fit to a mathematical
model of transvascular transport to yield a simulated profile.
Table 1. Parameter values and mean-square errors obtained
when fitting one hour perfusion data
Initial Values Final Values
Diffusivity (D) 12 um 2/s 15.29 um2/s
Endovascular Permeability (Pendo) 110 um/s 102.06 um/s
Perivascular Permeability (Pperi) 15 um/s 18.88 um/s
Mean-Square Error 7.68 x 10-5 4.67 x 10-5
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Figure 10. Concentration profiles for two hour perfusion
data. Arteries were perfused for two hour with no
transvascular concentration gradient, an endovascular bath of 1
mg/ml of FITC-Dx in PBS" and a perivascular bath of PBS".
The measured concentration profile was then fit to a
mathematical model of transvascular transport to yield a
simulated profile.
Table 2. Parameter values and mean-square errors obtained
when fitting two hour perfusion data
Initial Values Final Values
Diffusivity (D) 20 um 2/s 44.22 um2/s
Endovascular Permeability (Pendo) 50 um/s 25.64 um/s
Perivascular Permeability (Pperi) 25 um/s 7.83 um/s
Mean-Square Error 2.55 x 10-4 1.76 x 10-4
The success of an optimization algorithm, such as the parameter fitting routine in
these studies, is highly dependent on the estimated parameter values used to initiate the
algorithm. Estimates of parameter values were not available since previous research on
the transport of 20 kD dextrans in calf carotid arteries has been limited. An attempt to
modify values from similar studies in our laboratories examining the transport of heparin,
a similarly sized (6-30 kD) macromolecule, in the rat abdominal aorta were unsuccessful.
Therefore, measured and simulated profiles were compared by a user and parameter
values were adjusted until the profiles appeared similar. The fitting algorithm was then
used to further optimize parameter values.
The discrepancy in parameter values obtained from the one and two hour
perfusion data indicate that further investigation into both the experimental and
mathematical methodology is necessary. However, it appears that it is feasible to
calculate transport parameters by integrating the quantitative fluorescence microscopy
technique developed in the last chapter with mathematical modeling.
IV.F. Chapter Summary
The method developed to quantify macromolecular distributions in vascular tissue
described in the last chapter can be implemented with in vitro experiments to measure
important transport mechanisms such as diffusion and convection. These measurements
can then be used to construct better mathematical models which will further
understanding of vascular transport and deposition. Experiments using fluorescently
labeled 20 kD dextrans are proposed to demonstrate the measurement of transport
parameters such as convective velocity, molecular diffusivity, and drug partitioning. The
transport of macromolecules is dependent on factors such as the physico-chemical
properties of the compound, state of the vessel and local environment. Similar
experiments measuring these transport mechanisms would elucidate the relative
importance of these factors. This could then be assimilated into general principles
governing the transport and deposition of macromolecules in the vessel wall.
V. Conclusions
V.A. Accomplishments
Current methods to quantify macromolecular distributions in vascular tissues have
been limited by post-experiment artifact, low signal-to-noise ratios, low spatial
resolution, and the inability to provide multi-dimensional drug distribution profiles. This
has suggested the need to develop new tools to obtain better experimental data. The
quantitative fluorescent microscopy technique described in this work overcomes
limitations of previous techniques and will be a valuable tool for investigation into the
pharmacology and physiology of the vessel wall that determine the effect of bioactive
molecules in tissues. This new technique can be incorporated into future experiments to
gain insight into macromolecular transport and deposition within the vessel wall. This
knowledge can then be applied to the rational design of drug delivery strategies. To
illustrate the utility of this technique, the transvascular transport of fluorescently labeled
20 kD dextrans in the calf carotid artery was examined using an in vitro perfusion
apparatus that simulates plasma flow. A mathematical model was fit to measured
concentration profiles and provided estimates of important transport parameters such as
the effective diffusivity within tissue, and endovascular and perivascular permeabilities.
V.B. Future Directions
The quantitative fluorescence microscopy technique developed in this thesis
appears to be a very promising tool for future investigation into macromolecular
pharmacokinetics in vascular tissue. The discrepancy between transport parameters
obtained for the one hour and two hour perfusion data in the last chapter indicate that
there are still issues to be resolved. Currently, we are attempting to compare this
technique with enface serial sectioning to verify the accuracy of this technique. There are
also numerical issues involved with fitting measured concentration profiles to a
distributed model of transport that need to be investigated. The experimental data shown
here represent only a small portion of the different conditions that need to be examined to
better understand macromolecular pharmacokinetics in the vessel wall. Future
experiments and modeling need to examine issues such as the difference between
endovascular and perivascular delivery, the effect of convective forces, and intermittent
dosing.
In addition to examining different vessel conditions, this technique can be used to
examine different compounds. One possible research direction is to isolate the effect that
different physico-chemical properties have on the transport and deposition of a
compound. One would expect that molecular size would be a major determinant, but the
effects of other properties such as charge, solubility, and conformability, are often
overlooked and may have substantial effect on the transport of a compound. As
described in the previous chapter, dextrans are an ideal choice for these studies because
their physico-chemical properties are easily modifiable. The results could then be used to
develop a set of general principles that would predict the distribution of a compound
based on its physico-chemical properties.
The ability to provide multi-dimensional concentration profiles was not exploited
in this work, but may turn out to be one of this technique's most useful properties. It
may not be desirable, or even possible, to completely expose a vessel that requires
pharmacological treatment. Therefore, radially asymmetric delivery devices must be
employed. There is a limited understanding of the distribution following administration
from asymmetric devices, but the technique developed here may also be used to
investigate this area.
VI. Appendix
VI.A. Calculating Tissue Concentrations from Bulk
Incubation Concentrations
This section describes the derivation of an equation used to calculate the tissue
concentration of a specimen which was incubated in a fixed bulk concentration and then
reincubated in another bulk concentration to allow drug within the tissue to diffuse out of
the tissue. Tissue concentrations are calculated for an original bulk incubation
concentration of C, mg/ml, a bulk reincubation concentration of C, mg/ml, a wet tissue
weight of x mg, and fractional volume E. After the initial incubation, the amount of drug
in the tissue (q mg) before reincubation is
P
The drug redistributes in the reincubation bath (with volume V ml) and a mass balance
yields
q
C, =
P
Vp + Ex
Solving for the tissue concentration CT yields
CT = ECl
SC2 (Vp +Ex)
x
The volume of the reincubation bath is much larger than the fractional tissue volume
available to the drug during the original incubation, allowing the following approximation
to be made
V >> - = Vp >> EX
P
and the original tissue concentration to be approximated by
S= C2Vp
x
VI.B. Derivation of Equations for a Mathematical Model of
Transvascular Transport
The derivation of the basic equation of transvascular transport begins by defining
C(x, t) as the concentration of solute at a transvascular distance x from the internal
elastic lamina and time t. Two mechanisms of solute transport are incorporated in this
derivation: diffusion and convection. Diffusion across the element is proportional to the
concentration gradient and convection across the element is proportional to the
concentration at a particular point. In addition, both of these transport mechanisms are
proportional to the cross-sectional area. The transvascular flux at distance x from the
endothelium and time t, rans (x, t), is the sum of these two components
Jtrans (x, t) = jdiffsion (x, t) + convection (x, t)
ADC(x, t)
= -AD + AVC(x,t)
dx
where the parameters D (jlength 2/time) and V (length/time) represent the contributions
due to diffusion and convection, respectively. Define a infinitesimal three-dimensional
element centered at x, and let Vtem be the volume and A be the cross-sectional area of
this infinitesimal element (Velem = AAx). A mass balance across this element (assuming
there is no flux in the circumferential and longitudinal directions) yields the net flux across
the infinitesimal element:
Jnet (X, t) = trans (X, t)- jrans (X + Ax, t)
dx (x, t)
jtrans (x, t) AX
-AD 'C(x,t) +AV x I
dx dx
'net (X, t)- Velem D dx2 C(X, t) Cx
The net flux (mass/time) divided by the element volume is identical to the change in
concentration (mass/volume) with respect to time, therefore:
dC(x, t) _ jnet (x,t)
dt Velem
D 2 C(x,t) adC(x,t)
=D V
dx2  dx
The derivation of the boundary equation for the luminal membrane corresponding
to the endothelium and internal elastic lamina (x = 0) begins by defining an infinitesimal
three-dimensional element centered at x = 0 with cross-sectional area A. In addition to
the diffusive and convective effects described above for points within the media, there is
an additional component due to permeation through the luminal membrane. The
permeation across the luminal membrane is proportional to the concentration gradient
across the membrane and the cross-sectional area of the element. This concentration
gradient must be carefully defined since endovascular bath concentrations are expressed in
bulk phase concentrations and concentrations in the media are expressed as tissue
concentrations. The fraction of the tissue space the modeled compound can access must
be used to express the concentration gradient properly. The net flux across this
membrane is zero since the model assumes the membrane acts strictly as a barrier and
does not store any drug. Therefore, the algebraic sum of the permeation, diffusion, and
convection fluxes must equal zero:
Jpermeation (0 , t) + diffusion (0+, t) + jconvection (0+, t) = 0
PendoA C(O + t) Cendo (t)
r~~ c~',E
+(-AD J iCC(O = t)+ -AD + AVC(O + , t) = 0dx
Rearranging terms gives the boundary equation for the endovascular membrane:
D C(o , et)d= P ndC(O+,t) C endo (t) + VC( ,t)
D , t)= Pendo (t) + V C ( x t )dx IEI x=0
The derivation for the boundary equation for the perivascular membrane proceeds
similarly.
Programming Code for Transport Model and
Parameter Fitting Routine
VI.C.1. Parameter Fitting Routine (ww_trans_fit.m)
% ww_trans_fit.m
% Parameter fitting algorithm. Calls "ww_trans_model" and "ww_trans_error"
% Wade Wan
% February 1, 1998
tic
% Load measured concentration profiles
pathstr='CORNHOLIO:Desktop Folder:CORNHOLIO Users:Wade:7/20/97 Analysis:';
cd(pathstr);
load bulk72097;
const=[];
for iii= 1:3
switch iii
case 1,totalt= 120;y=bulk72097(15:325,1);
case 2,totalt=90;y=bulk72097(5:315,2);
case 3,totalt=60;y=bulk72097( 15:295,3);
end
x=(l:length(y))* 1.326;
Eps=0.5233;
y=y*Eps;
% Fixed parameters
VI. C.
Cev= 1;
Cpv=0;
V=0;
Lmed=length(y)* 1.326;
% Variable parameters, [D Rend Radv]
paramorig=[20 50 25];
% disp. interm., tolerance for x, tolerance for F(x), .... max. eval.
% options(1),(2),(3),(14) default 0,1.e-4, 1.e-4....,200*length(x)
defaultopt=foptions;
% defaultopt(14)=5;
paramfit=fmins('ww_trans_error',paramorig,defaultopt,[],[totalt Cev Cpv V Lmed,Eps],y');
% ww_trans_model(D,Eps,Rend,Radv,totalt,Cev,Cpv,V,Lmed,testplot);
yfit=ww_trans_model(paramfit( 1),Eps,paramfit(2),paramfit(3),totalt,Cev,Cpv,V,Lmed,0);
Nyfit=length(yfit)-2;
xfit=[0 (1 :Nyfit)*Lmed/(Nyfit+1) Lmed];
hold on;
plot(x,y,'r',xfit,yfit,'b');
xlabel('Distance from the Endothelium (um)');
ylabel('Transvascular Tissue Concentration (mg/ml)');
title(['D Rend Radv=[' num2str(paramorig)' -->' num2str(paramfit) ']');
hold off;
disp(paramfit);
const=[const; paramfit];
end % iii
toc
VI.C.2. Mathematical Model of Transport (ww_trans_model.m)
function [transprofile]=ww_trans_model(D,Eps,Rend,Radv,totalt,Cev,Cpv,V,Lmed,testplot);
% ww_trans_model.m
% function [transprofile]=ww trans_model(D,Eps,Rend,Radv,totalt,Cev,Cpv,V,Lmed,testplot);
% Model of transvascular transport with nodes in the media, endovascular and perivascular permeabilities
% Wade Wan
% February 1, 1998
% Default Settings
if (nargin<1)
D= 12; % umA2/s
end
if (nargin<2)
Eps=0.5; %
end
if (nargin<3)
Rend=250; % s/um
end
if (nargin<4)
Radv=60000; % s/um
end
if (nargin<5)
totalt=60; % min
end
totalt=totalt*60; % min ---> s
if (nargin<6)
Cev=l; % mg/ml
end
if (nargin<7)
Cpv=O; % mg/ml
end
if (nargin<8)
V=O; %
end
if (nargin<9)
Lmed=400; % um
end
if (nargin<10)
testplot= 1;
end
dt=1; % s
ninc=totalt/dt;
Nmed=40;
Ntot=Nmed+2; % One node at each boundary (endovascular, perivascular)
Lmednode=Lmed/(Nmed+ 1);
% Initial Loading Conditions
Cx_t = zeros(Ntot,ninc);
if (Rend=O)
Cx_t(1, 1)=Cev*Eps;
else
Cx_t( 1,1)=Cev*Lmednode*Eps/Rend/(D*Eps+Lmednode/Rend+V*Lmednode*Eps);
end
if (Radv=O)
Cx_t(Ntot, 1)=Cpv*Eps;
else
Cx_t(Ntot, 1)=Cpv*Lmednode*Eps/Radv/(D*Eps+Lmednode/Radv-V*Lmednode*Eps);
end
% Simulation
for xtime=2:ninc
if (Rend==O)
Cx_t(1,xtime)=Cev*Eps;
else
Cxt(1,xtime)=(D*Eps*Cx_t(2,xtime-
1)+Cev*Lmednode*Eps/Rend)/(D*Eps+Lmednode/Rend+V*Lmednode*Eps);
end
if (Radv=O)
Cx_t(Ntot,xtime)=Cpv*Eps;
else
Cx_t(Ntot,xtime)=(D*Eps*Cx_t(Ntot- 1 ,xtime- 1)+Cpv*Lmednode*Eps/Radv)/(D*Eps+Lmednode/Radv-
V*Lmednode*Eps);
end
d2C_dx2=(Cx_t(3:(Nmed+2),xtime- 1 )-2*Cx_t(2:(Nmed+1),xtime- 1)+Cx_t( 1 :Nmed,xtime-
1))/(LmednodeA2);
dC_dx=(Cx_t(3:(Nmed+2),xtime- 1)-Cx_t(2:(Nmed+1),xtime- 1))/Lmednode;
dCx_t=D*d2C_dx2-V*dC_dx;
Cx_t(2:(Nmed+1),xtime)= Cx_t(2:(Nmed+1 ),xtime-1)+dCx_t*dt;
end % xtime
transprofile=Cx_t(:,ninc);
if (testplot== 1)
% bndlength=50;
hold on;
% plot(-bndlength: 1:0,Cev*ones(bndlength+ 1,1),'g',...
% Lmed: 1 :(Lmed+bndlength),Cpv*ones(bndlength+1,1),'g',...
% [0 0],[0 max([Cpv Cev])],'m', ...
% [Lmed Lmed],[O max([Cpv Cev])],'m');
% xlabel('Distance from Endothelium/IEL (um)');
% ylabel('Concentration (mg/ml)');
xvar-[0 (1 :Nmed)*Lmednode Lmed];
plot(xvar,transprofile,'-.');
% yheight=1.25*max(Cx_t(:,ninc));
% axis([-bndlength Lmed+bndlength 0 yheight]);
% title(['[D Eps Rend Radv t V] =' num2str([D Eps Rend Radv totalt/60 V])]);
% text(-bndlength*3/4,yheight*0.9,'EV');
% text(Lmed/4,yheight*0.9,'Media');
% text(Lmed+bndlength/4,yheight*0.9,'PV');
hold off;
end
VI.C.3. Error Function (ww_trans_error.m)
function ferror=-ww_trans_error(paramalter,param_fix,data)
% ww_trans_error.m
% function ferror=-ww_trans_error(param_alter,paramfix,data)
% Calculates the error between measured and simulated profiles for use with "fmins"
% Wade Wan
% February 1, 1998
% Variable parameters
D=param_alter(1);
Rend=param_alter(2);
Radv=param_alter(3);
% Fixed parameters
totalt=param_fix( 1);
Cev=param_fix(2);
Cpv=param_fix(3);
V=param_fix(4);
Lmed=param_fix(5);
Eps=param_fix(6);
if min(param_alter)<0
ferror=- 10000;
disp(['***Negative Parameter:' num2str(ferror) ' =====> Parameters:' num2str(paramalter)]);
else
%simy=ww_trans_model(D,Eps,Rend,Radv,totalt,Cev,Cpv,V,Lmed,0);
simy=ww_trans_model(D,Eps,Rend,Radv,totalt,Cev,Cpv,V,Lmed,0);
Nsim=length(simy)-2;
simx=[0 (1 :Nsim)*Lmed/(Nsim+1) Lmed];
Nexp=length(data)-2;
expx=[0 (1 :Nexp)*Lmed/(Nexp+1) Lmed];
expy=interp 1 (expx,data,simx,'*linear')';
% Interpolates to find corresponding concentrations in measured profile
plot(simx,simy,'x',simx,expy,'o');
legend('Simulation','Experimental');
ferror=-mean((simy-expy).^2);
disp(['Error: ' num2str(ferror)' =====> Parameters: ' num2str(param_alter)]);
drawnow;
end
VI.D. Experimental Data
Table 3. Experimental data for Figure 3 (Tissue Concentration as a
Function of Incubation Time)
Incubation Tissue Concentration (mg/mi) Mean Standard
Time (hr) # 1 # 2 # 3 Deviation
1 0.48 0.43 0.48 0.46 0.03
2 0.42 0.44 0.49 0.45 0.04
4 0.46 0.59 0.57 0.54 0.07
6 0.56 0.57 0.62 0.58 0.03
16 0.61 0.56 0.55 0.57 0.03
20 0.59 0.62 0.60 0.60 0.02
24 0.60 0.61 0.59 0.60 0.01
40 0.57 0.65 0.59 0.60 0.04
48 0.55 0.61 0.63 0.60 0.04
Table 4. Experimental data for Figure 6 (Fluorescent Intensity as a
Function of Incubation Concentration)
Incubation Specimen # Section # Mean Standard
Concentration Deviation
(mg/mi)
2.50 2 4 145.88 10.25
2.50 2 5 163.64 11.56
2.50 2 6 166.13 8.05
158.55 5.81
2.00 2 4 145.94 13.70
2.00 2 5 152.10 18.06
2.00 2 6 126.21 10.01
141.41 8.26
1.00 2 4 100.41 8.47
1.00 2 5 76.82 6.81
1.00 2 6 80.96 10.00
86.06 4.92
0.50 1 4 58.25 4.53
0.50 1 5 49.85 4.02
0.50 1 6 55.75 4.33
54.62 2.48
0.25 2 4 43.38 3.92
0.25 2 5 34.76 5.87
0.25 2 6 50.77 3.17
42.97 2.58
0.20 1 4 38.44 3.03
0.20 1 5 31.13 2.79
0.20 1 6 40.99 2.67
36.85 1 .64
0.15 1 4 23.99 2.21
0.15 1 5 36.05 2.49
0.15 1 6 37.84 3.29
32.63 1 .56
0.10 2 4 15.31 1.76
0.10 2 5 16.46 1.98
0.10 2 6 23.16 4.00
18.31 1 .60
0.05 2 4 6.77 1.77
0.05 2 5 6.81 2.85
0.05 2 6 8.18 2.05
7.25 1.31
0.02 2 4 3.59 1.42
0.02 2 5 4.66 1.52
0.02 2 6 5.66 1.41
4.64 0.84
Table 5. Experimental data for Figure 7 (Tissue Concentration as a
Function of Bulk Phase Concentration)
Bulk Phase Tissue Concentration (mg/ml) Mean Standard
Concentration # 1 # 2 # 3 Deviation
(mg/ml)
0.5 0.334 0.284 0.315 0.311 0.025
0.6 0.325 0.353 0.281 0.320 0.036
0.7 0.374 0.419 0.375 0.389 0.026
0.8 0.386 0.342 0.476 0.401 0.068
0.9 0.455 0.399 0.462 0.439 0.034
1.0 0.497 0.534 0.534 0.522 0.021
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